SREBF1 and neoplasm: In contrast, resveratrol, a well-studied polyphenol, mainly targets lipid metabolism by inhibiting FASN and SREBP1, activating the SIRT1–AMPK axis, and altering sphingolipid and cholesterol metabolism, thereby inducing metabolic stress and apoptosis in tumor cells [113].